Mergers & AcquisitionsBy The Online Investor Staff, updated Fri., Jan. 22, 4:11 PM
|This Slide: #2 of 100|
Slide #2. Ehave, Inc. — CureDash Assets
Ehave, Inc. (EHVVF)
Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it completed the transaction to acquire the assets of IV therapy service CureDash www.curedash.com. The CureDash assets include an IV delivery platform that will become the backbone of KetaDASH www.ketadash.com. KetaDASH will provide the platform for medical practitioners to administer ketamine intravenously to patients at home. Ketamine is widely used to lessen the amount of potentially addictive pain medication required after certain medical procedures. Ketamine is now being studied as a treatment for major depression, though it has not yet been approved by the FDA to treat depression.
Buy (2.67 out of 4)